Mechanism of Abnormal Coagulation Induced by Tigecycline in Cancer Patients

Mechanism of Abnormal Coagulation Induced by Tigecycline in Cancer Patients

Tigecycline is a broad-spectrum active intravenous antibiotic that is active against methicillin-resistant staphylococcus aureus. In Phase 3 and 4 clinical trials, increased all-cause mortality was observed in patients treated with tigecycline compared to patients in the control group. The reason fo...

Full description

Bibliographic Details
Main Authors:	Li-Hua Sun, Kun-Hao Bai, Guo-Yan Wu, Xiao-Peng Tian, Zhi-Qing Zou, Da-Wei Wang, Yu-Jun Dai, Si-Liang Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Pharmacology
Subjects:	tigecycline abnormal coagulation cancer RNA-Seq CHO
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.891952/full

Similar Items

Risk Factors for Tigecycline-Associated Hypofibrinogenemia
by: Liu J, et al.
Published: (2021-04-01)

Clinical Manifestations and Risk Factors of Tigecycline-Associated Thrombocytopenia
by: Zhu Y, et al.
Published: (2023-09-01)

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
by: Lei Zhang, et al.
Published: (2023-06-01)

Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
by: Frontiers Production Office
Published: (2024-01-01)

Cerebrospinal fluid penetration of tigecycline
by: Carlo Pallotto, et al.
Published: (2014-08-01)

Resistance mechanisms of tigecycline in Acinetobacter baumannii
by: Chunli Sun, et al.
Published: (2023-05-01)

Tigecycline for severe Clostridium difficile infection
by: Ashley Thomas, et al.
Published: (2014-09-01)

Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecycline
by: Trupti Patel, et al.
Published: (2012-04-01)

Tigecycline and Community-Acquired Pneumonia
by: Sercan ULUSOY
Published: (2013-12-01)

Coagulation abnormalities as predictors of renal dysfunction in heart failure with reduced ejection fraction
by: Paula Połaska, et al.
Published: (2023-06-01)

In vitro activity of tigecycline and proteomic analysis of tigecycline adaptation strategies in clinical Enterococcus faecalis isolates from China
by: Bing Bai, et al.
Published: (2022-09-01)

In vitro and in vivo antibacterial activity of tigecycline against Vibrio vulnificus
by: Hung-Jen Tang, et al.
Published: (2018-02-01)

A Lesser Known Side Effect of Tigecycline: Hypofibrinogenemia
by: Fulya Yılmaz Duran, et al.
Published: (2018-02-01)

Tigecycline Interferes with Fibrinogen Polymerization Independent of Peripheral Interactions with the Coagulation System
by: Anna Brandtner, et al.
Published: (2020-02-01)

Population Pharmacokinetics of Tigecycline: A Systematic Review
by: Zhou CC, et al.
Published: (2022-06-01)

Multiple Mechanisms of Tigecycline Resistance in Enterobacteriaceae from a Pig Farm, China
by: Jing Wang, et al.
Published: (2021-10-01)

Drug-induced leukocytoclastic vasculitis: tigecycline a rare cause
by: Kalpana Bhairavarasu, et al.
Published: (2015-01-01)

Tigecycline Absorption Improved by Selected Excipients
by: Hubert Ziółkowski, et al.
Published: (2023-08-01)

Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China
by: Bing Leng, et al.
Published: (2022-10-01)

Overview of tigecycline and its role in the era of antibiotic resistance
by: Flávia Rossi, et al.

Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
by: Maria Kipourou, et al.
Published: (2023-02-01)

Tigecycline: a review of the literature
by: Mario Venditti, et al.
Published: (2006-01-01)

Five-Years Tigecycline Experience an Analysis of Real-Life Data
by: Fatih Temocin, et al.
Published: (2018-06-01)

Comparative pharmacokinetics of chlortetracycline, tetracycline, minocycline, and tigecycline in broiler chickens
by: Hubert Ziółkowski, et al.
Published: (2020-10-01)

Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection
by: Yuan-Pin Hung, et al.
Published: (2015-06-01)

Coagulation Abnormalities in Pediatric Patients with Congenital Heart Disease: A Literature Review
by: Ali Ghasemi, et al.
Published: (2014-04-01)

Evaluation of tigecycline activity in clinical isolates among Indian medical centers
by: Manoharan Anand, et al.
Published: (2010-10-01)

In Vitro Susceptibility of Tigecycline and Colistin Against Stenotrophomonas maltophilia
by: Turhan TOGAN, et al.
Published: (2018-03-01)

Switch therapy in hospitalized patients with community-acquired pneumonia: Tigecycline vs. Levofloxacin
by: Ramirez Julio A, et al.
Published: (2012-07-01)

Emergence of carbapenem- and tigecycline-resistant Klebsiella pneumoniae ST617
by: Lin Sun, et al.
Published: (2022-06-01)

Immunomodulatory Effects of Tigecycline in Balb/C Mice
by: Elhayek Shada Y., et al.
Published: (2018-12-01)

Coagulation abnormalities and their relationship with bleeding manifestations in patients with dengue-A single center observational study
by: Govind R Patel, et al.
Published: (2023-01-01)

Tigecycline-induced sustained severe hypoglycemia: a case report
by: Yixin Chen, et al.
Published: (2019-08-01)

Teicoplanin – Tigecycline Combination Shows Synergy Against Mycobacterium abscessus
by: Dinah B. Aziz, et al.
Published: (2018-05-01)

Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii
by: Jeongwoo Jo, et al.
Published: (2021-10-01)

Association of circulating proprotein convertase subtilisin/kexin type 9 concentration with coagulation abnormalities in patients with primary membranous nephropathy
by: Huizi Zhu, et al.
Published: (2023-12-01)

Genome sequence of a tigecycline-resistant Acinetobacter seifertii recovered in human bloodstream infection in China
by: Donghong Gao, et al.
Published: (2023-09-01)

A method for screening tigecycline-resistant gene tet(X) from human gut
by: Yu Zeng, et al.
Published: (2021-03-01)

Comparison of minimal inhibitory concentrations (MICs) of tigecycline in 2011 and 2015 years against multidrug-resistance acinetobacter baumannii strains
by: Yucel Duman, et al.
Published: (2017-03-01)

A Novel Tigecycline Adjuvant ML-7 Reverses the Susceptibility of Tigecycline-Resistant Klebsiella pneumoniae
by: Lilan Sun, et al.
Published: (2022-01-01)